Paul A Friedman sold $12.5M of Madrigal Pharmaceuticals (MDGL)

Executed Jan 9, disclosed Jan 13, 4 days later.

Value, as filed

$12.5M

24,006 sh across 23 lots

Executed

Jan 9

the trade date, as filed

Disclosed

Jan 13

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Paul A Friedman Director profile →

Paul A Friedman (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $13.6M of MDGL (24,640 sh across 8 lots, as filed), executed Dec 10 2025.

The name

MDGL

Madrigal Pharmaceuticals, Inc. MDGL · Healthcare · 59 filings in 24 months ticker →

Healthcare · Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Paul A Friedman in MDGL

MDGLSALE Madrigal Pharmaceuticals, Inc. $154K
280 sh × $551.24
Exec Jan 9
Filed Jan 13 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $13.6M
24,640 sh across 8 lots
Exec Dec 10 2025
Filed Dec 12 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $47.8M
129,172 sh across 17 lots
Exec Aug 13 2025
Filed Aug 13 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $16.6M
46,808 sh across 12 lots
Exec Aug 11 2025
Filed Aug 13 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $490K
1,400 sh × $350.03
Exec Jul 18 2025
Filed Jul 22 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $10.2M
28,876 sh across 9 lots
Exec Jul 16 2025
Filed Jul 18 2025 · 5:30 PM ET